CUTR Cutera Inc Total Debt to Capital

CUTR (Cutera, Inc) - company brandmark

Cutera, Inc. (CUTR) is a technological pioneer in energy-based aesthetic systems, actively developing unique innovations in non-invasive body contouring. This price chart, which assists in the basic asset valuation, demonstrates a debt-to-equity ratio of 0.00, complementing data on the implementation of robotic lines in the production of laser devices. Business stability is guaranteed by the neutral status of biomedicine and the humanitarian nature of the products.

Cutera - CUTR Debt to Capital (period 07/04/2022 - 03/22/2025)
Finished products of Cutera, Inc.

A steady inflow of funds from the sale of laser systems allows Cutera, Inc. (CUTR) to maintain operational activities despite the need for costly technological upgrades. By analyzing the company's leverage history, an investor assesses the proportion of debt relative to equity, which determines the degree of financial autonomy and the resilience of share prices amid slowing market demand.

Analysis of competing companies

Dexcom (DXCM) - Total Debt to Equity Ratio|Aggregate Debt to Capital Penumbra Inc|Novanta Corp (NOVT) - Total Debt to Capital|All Debt to Shareholders' Equity Ratio Haemonetics Company (HAE)|INSP: Total Debt to Capital|procept-biorobotics.com - Debt to Capital|Debt to Equity CONMED (CNMD)|PLSE - All Debt to Shareholders' Equity Ratio|INMD: Total Debt to Capital|PMI (Picard Group) - Total Debt to Capital|Debt to Equity Surmodics, Inc. SRDX|Aggregate Debt to Equity Senseonics Corp|NeuroPace - Total Debt to Capital|Debt to Capital tactilemedical.com TCMD|Total Debt to Equity Ratio SNWV (SANUWAVE Health, Inc.)|OM - Total Debt to Capital|Total Debt to Equity Ratio Electromed Inc ELMD|LNSR - Aggregate Debt to Capital|AVITA Medical - Total Debt to Capital|Profound Medical (PROF) - Total Debt to Capital Coefficient|Total Debt to Capital BDMD|Total Debt to Equity Ratio EDAP Medical (EDAP)|Apyx Medical (APYX) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio ICCM (icecure-medical.com)|Pulmonx - Debt to Equity|Total Debt to Equity Ratio TELA Bio Inc. TELA|CTSO (CytoSorbents Corp.) - Total Debt to Capital|SRTS - Debt to Capital|Total Debt to Capital Zynex, Inc.|electroCore (ECOR) - Debt to Equity Ratio|RBOT: Total Debt to Capital|Total Debt to Capital Coefficient Inspira Technologies Oxy B.H.N. Ltd|Total Debt to Capital ICU (SeaStar Medical Holding Corp)|Total Debt to Equity Ratio iridex.com (IRIX)|Total Debt to Capital INBS (Intelligent Bio Solutions Inc.)|Beyond Air Inc - Total Debt to Capital|PFSA - Debt to Equity|STRATA Skin Sciences (SSKN) - Debt to Equity|Total Debt to Equity Ratio GlucoTrack GCTK|NanoVibronix Inc. (NAOV) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital VERO (Venus Concept Inc.)|Debt to Capital NUWE|AEMD: Debt to Equity|Debt to Capital Ratio asensus.com ASXC|Total Debt to Equity Ratio AVGR (Avinger, Inc)|Total Debt to Capital BioSig Technologies Inc. BSGM|Total Debt to Capital KNW (Know Labs, Inc.)|NARI: Total Debt to Capital Coefficient|Debt to Equity Nevro (NVRO)|RSLS (ReShape Lifesciences Inc.) - Aggregate Debt to Equity|Debt to Equity SILK